Test Code 1030FL

Test Name Carisoprodol and Metabolite, Fluid

Purpose
Therapeutic Drug Monitoring
Method(s)
Gas Chromatography/Mass Spectrometry (GC/MS)
Suggested CPT Code(s)
80369
New York State Approval Status

Approved

Turnaround Time

8 days

Test Includes
1 Carisoprodol Soma® Gas Chromatography/Mass Spectrometry (GC/MS) mcg/mL 0.2 Muscle Relaxant
2 Meprobamate Carisoprodol Metabolite Gas Chromatography/Mass Spectrometry (GC/MS) mcg/mL 1 Muscle Relaxant

Compliance Statement
This test was developed and its performance characteristics determined by NMS Labs. It has not been cleared or approved by the US Food and Drug Administration.
Specimen Type
Fluid
Requested Volume
2 mL
Minimum Volume
0.7 mL
Special Handling
None
Specimen Container
Plastic container (preservative-free)

Additional Collection Instructions

Transport Temperature
Refrigerated
Light Protection
Not Required
Rejection Criteria
None

Rejection criteria pertain to clinical specimen submissions only.

Stability
Room Temperature: Undetermined
Refrigerated: Undetermined
Frozen (-20 °C): Undetermined
1 Carisoprodol Soma® Gas Chromatography/Mass Spectrometry (GC/MS) mcg/mL 0.2 Muscle Relaxant
2 Meprobamate Carisoprodol Metabolite Gas Chromatography/Mass Spectrometry (GC/MS) mcg/mL 1 Muscle Relaxant

Interface Map

LOINC® Information

The CPT Codes provided in this document are based on AMA Guidelines and are for informational purposes only. NMS Labs Does not assume responsibility for billing errors due to Reliance on the CPT Codes listed in this document.

*The information contained in this document represents database configurations, as they will appear on the effective date listed above.